Evidence for a key role of leptin in osteoarthritis.

OBJECTIVE To evaluate the contribution of leptin (an adipose tissue-derived hormone) to the pathophysiology of osteoarthritis (OA), by determining the level of leptin in both synovial fluid (SF) and cartilage specimens obtained from human joints. We also investigated the effect of leptin on cartilage, using intraarticular injections of leptin in rats. METHODS Leptin levels in SF samples obtained from OA patients undergoing either knee replacement surgery or knee arthroscopy were measured by enzyme-linked immunosorbent assay. In addition, histologic sections of articular cartilage and osteophytes obtained during surgery for total knee replacement were graded using the Mankin score, and were immunostained using antibodies to leptin, transforming growth factor beta (TGFbeta), and insulin-like growth factor 1 (IGF-1). For experimental studies, various doses of leptin (10, 30, 100, and 300 microg) were injected into the knee joints of rats. Tibial plateaus were collected and processed for proteoglycan synthesis by radiolabeled sulfate incorporation, and for expression of leptin, its receptor (Ob-Rb), and growth factors by reverse transcriptase-polymerase chain reaction and immunohistochemical analysis. RESULTS Leptin was observed in SF obtained from human OA-affected joints, and leptin concentrations correlated with the body mass index. Marked expression of the protein was observed in OA cartilage and in osteophytes, while in normal cartilage, few chondrocytes produced leptin. Furthermore, the pattern and level of leptin expression were related to the grade of cartilage destruction and paralleled those of growth factors (IGF-1 and TGFbeta1). Animal studies showed that leptin strongly stimulated anabolic functions of chondrocytes and induced the synthesis of IGF-1 and TGFbeta1 in cartilage at both the messenger RNA and the protein levels. CONCLUSION These findings suggest a new peripheral function of leptin as a key regulator of chondrocyte metabolism, and indicate that leptin may play an important role in the pathophysiology of OA.

[1]  Patricia Ducy,et al.  Leptin Regulates Bone Formation via the Sympathetic Nervous System , 2002, Cell.

[2]  W. B. van den Berg,et al.  Inhibition of Endogenous TGF-β During Experimental Osteoarthritis Prevents Osteophyte Formation and Impairs Cartilage Repair , 2002, The Journal of Immunology.

[3]  M. Phillip,et al.  Leptin Acts as a Growth Factor on the Chondrocytes of Skeletal Growth Centers , 2002, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[4]  D. Heymann,et al.  Recent advances in TGF-β effects on chondrocyte metabolism , 2002 .

[5]  K. Satomura,et al.  Potential Role of Leptin in Endochondral Ossification , 2002, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[6]  R. Faggioni,et al.  Leptin regulation of the immune response and the immunodeficiency of malnutrition 1 , 2001, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[7]  John P Allegrante,et al.  Body mass indices in patients with disabling hip osteoarthritis , 2001, Arthritis research.

[8]  G. Knutsen,et al.  Human articular chondrocytes express functional leptin receptors. , 2001, Biochemical and biophysical research communications.

[9]  J. Whitfield,et al.  Leptin: brains and bones , 2001, Expert opinion on investigational drugs.

[10]  P. Jones,et al.  Leptin and its role in lipid metabolism , 2001, Current opinion in lipidology.

[11]  Richard M Aspden,et al.  Osteoarthritis as a systemic disorder including stromal cell differentiation and lipid metabolism , 2001, The Lancet.

[12]  P. Sime,et al.  Overexpression of active TGF-beta-1 in the murine knee joint: evidence for synovial-layer-dependent chondro-osteophyte formation. , 2001, Osteoarthritis and cartilage.

[13]  G. Fantuzzi,et al.  Leptin in the regulation of immunity, inflammation, and hematopoiesis , 2000, Journal of leukocyte biology.

[14]  J. Pelletier,et al.  Modulation of collagenase 3 in human osteoarthritic cartilage by activation of extracellular transforming growth factor β: Role of furin convertase , 2000 .

[15]  C. Steppan,et al.  Leptin is a potent stimulator of bone growth in ob/ob mice , 2000, Regulatory Peptides.

[16]  H. Minehara,et al.  Growth Factor Expression in the Osteophytes of the Human Femoral Head in Osteoarthritis , 2000, Clinical orthopaedics and related research.

[17]  J. Vincent,et al.  Binding of a pure 125I-monoiodoleptin analog to mouse tissues: a developmental study , 2000, Peptides.

[18]  Arndt F Schilling,et al.  Leptin Inhibits Bone Formation through a Hypothalamic Relay A Central Control of Bone Mass , 2000, Cell.

[19]  Y. Iwamoto,et al.  Expression of insulin-like growth factor I messenger ribonucleic acid in developing osteophytes in murine experimental osteoarthritis and in rats inoculated with growth hormone-secreting tumor. , 1999, Endocrinology.

[20]  A. Loudon,et al.  Leptin actions on food intake and body temperature are mediated by IL-1. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[21]  J. Sieper,et al.  Immunohistological analysis of cytokine expression in human osteoarthritic and healthy cartilage. , 1999, The Journal of rheumatology.

[22]  D. Felson,et al.  Body weight, body mass index, and incident symptomatic osteoarthritis of the hand, hip, and knee. , 1999, Epidemiology.

[23]  Y. Guisez,et al.  Leptin Is an Endogenous Protective Protein against the Toxicity Exerted by Tumor Necrosis Factor , 1999, The Journal of experimental medicine.

[24]  G. Garcı́a-Cardeña,et al.  Biological action of leptin as an angiogenic factor. , 1998, Science.

[25]  W. B. van den Berg,et al.  Stimulation of articular cartilage repair in established arthritis by local administration of transforming growth factor-beta into murine knee joints. , 1998, Laboratory investigation; a journal of technical methods and pathology.

[26]  C. Elson,et al.  Chondrocyte tumor necrosis factor receptors and focal loss of cartilage in osteoarthritis. , 1997, Osteoarthritis and cartilage.

[27]  N. Hoggard,et al.  Leptin and leptin receptor mRNA and protein expression in the murine fetus and placenta. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[28]  R. Mason,et al.  Chondrocyte cytokine and growth factor expression in murine osteoarthritis. , 1997, Osteoarthritis and cartilage.

[29]  K. Moar,et al.  Localization of leptin receptor mRNA splice variants in murine peripheral tissues by RT-PCR and in situ hybridization. , 1997, Biochemical and biophysical research communications.

[30]  T. Aigner,et al.  Suppression of cartilage matrix gene expression in upper zone chondrocytes of osteoarthritic cartilage. , 1997, Arthritis and rheumatism.

[31]  K. Mounzih,et al.  Early Onset of Reproductive Function in Normal Female Mice Treated with Leptin , 1997, Science.

[32]  J. Pelletier,et al.  IGF and IGF-binding protein system in the synovial fluid of osteoarthritic and rheumatoid arthritic patients. , 1996, Osteoarthritis and cartilage.

[33]  J. Pelletier,et al.  Prostaglandin E2 stimulates incorporation of proline into collagenase digestible proteins in human articular chondrocytes: identification of an effector autocrine loop involving insulin-like growth factor I , 1996, Molecular and Cellular Endocrinology.

[34]  R. Considine,et al.  Gender differences in serum leptin levels in humans. , 1996, Biochemical and molecular medicine.

[35]  R. Seeley,et al.  Identification of targets of leptin action in rat hypothalamus. , 1996, The Journal of clinical investigation.

[36]  J. Darnell,et al.  Leptin activation of Stat3 in the hypothalamus of wild–type and ob/ob mice but not db/db mice , 1996, Nature Genetics.

[37]  L. Tartaglia,et al.  The full-length leptin receptor has signaling capabilities of interleukin 6-type cytokine receptors. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[38]  O. Johnell,et al.  Effect of transforming growth factor‐β and platelet‐derived growth factor‐BB on articular cartilage in rats , 1996, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.

[39]  T. Spector,et al.  The association of obesity with osteoarthritis of the hand and knee in women: a twin study. , 1996, The Journal of rheumatology.

[40]  R. Skoda,et al.  Defective STAT signaling by the leptin receptor in diabetic mice. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[41]  E. Märker-Hermann,et al.  Different cytokine profiles in the synovial fluid of patients with osteoarthritis, rheumatoid arthritis and seronegative spondylarthropathies. , 1996, Clinical and experimental rheumatology.

[42]  J. Tyler,et al.  Insulin-like growth factor (IGF) receptor, IGF-I, interleukin-1 beta (IL-1 beta), and IL-6 mRNA expression in osteoarthritic and normal human cartilage. , 1996, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[43]  C. Westacott,et al.  Cytokines in osteoarthritis: mediators or markers of joint destruction? , 1996, Seminars in arthritis and rheumatism.

[44]  Rene Devos,et al.  Identification and expression cloning of a leptin receptor, OB-R , 1995, Cell.

[45]  T. Aigner,et al.  Differential expression of collagen types I, II, III, and X in human osteophytes. , 1995, Laboratory investigation; a journal of technical methods and pathology.

[46]  M. Pelleymounter,et al.  Effects of the obese gene product on body weight regulation in ob/ob mice. , 1995, Science.

[47]  R. Devos,et al.  Recombinant mouse OB protein: evidence for a peripheral signal linking adiposity and central neural networks. , 1995, Science.

[48]  Steven L. Cohen,et al.  Weight-reducing effects of the plasma protein encoded by the obese gene. , 1995, Science.

[49]  K. Nakao,et al.  Human Obese Gene Expression: Adipocyte-Specific Expression and Regional Differences in the Adipose Tissue , 1995, Diabetes.

[50]  J. Beresford,et al.  Osteoblasts and osteoclasts in adult human osteophyte tissue express the mRNAs for insulin-like growth factors I and II and the type 1 IGF receptor. , 1995, Bone.

[51]  M. Maffei,et al.  Positional cloning of the mouse obese gene and its human homologue , 1994, Nature.

[52]  W. B. van den Berg,et al.  In vivo protection against interleukin-1-induced articular cartilage damage by transforming growth factor-beta 1: age-related differences. , 1994, Annals of the rheumatic diseases.

[53]  W. B. van den Berg,et al.  Transforming growth factor-beta 1 stimulates articular chondrocyte proteoglycan synthesis and induces osteophyte formation in the murine knee joint. , 1994, Laboratory investigation; a journal of technical methods and pathology.

[54]  S. Yamashita,et al.  Effects of interleukin-1 beta on insulin-like growth factor-I autocrine/paracrine axis in cultured rat articular chondrocytes. , 1994, Annals of the rheumatic diseases.

[55]  J. Pelletier,et al.  The interleukin-1 receptor in normal and osteoarthritic human articular chondrocytes. Identification as the type I receptor and analysis of binding kinetics and biologic function. , 1992, Arthritis and rheumatism.

[56]  F. Luyten,et al.  Insulin-like growth factors maintain steady-state metabolism of proteoglycans in bovine articular cartilage explants. , 1988, Archives of biochemistry and biophysics.

[57]  R. Moskowitz,et al.  Development of criteria for the classification and reporting of osteoarthritis. Classification of osteoarthritis of the knee. Diagnostic and Therapeutic Criteria Committee of the American Rheumatism Association. , 1986, Arthritis and rheumatism.

[58]  H. Muir,et al.  In vivo and in vitro stimulation of chondrocyte biosynthetic activity in early experimental osteoarthritis. , 1984, Arthritis and rheumatism.

[59]  H. Dorfman,et al.  Biochemical and metabolic abnormalities in articular cartilage from osteo-arthritic human hips. II. Correlation of morphology with biochemical and metabolic data. , 1971, The Journal of bone and joint surgery. American volume.

[60]  H J Mankin,et al.  Biochemical and metabolic abnormalities in articular cartilage from osteo-arthritic human hips. , 1970, The Journal of bone and joint surgery. American volume.

[61]  Ash Je.  Howard Thomas Karsner. , 1958 .

[62]  C. Drevon,et al.  Leptin stimulates human osteoblastic cell proliferation, de novo collagen synthesis, and mineralization: Impact on differentiation markers, apoptosis, and osteoclastic signaling , 2002, Journal of cellular biochemistry.

[63]  W. B. van den Berg,et al.  Osteoarthritis-like changes in the murine knee joint resulting from intra-articular transforming growth factor-beta injections. , 2000, Osteoarthritis and cartilage.

[64]  M. Goldring.  The role of cytokines as inflammatory mediators in osteoarthritis: lessons from animal models. , 1999, Connective tissue research.

[65]  G. Fantuzzi,et al.  Leptin deficiency enhances sensitivity to endotoxin-induced lethality. , 1999, American journal of physiology. Regulatory, integrative and comparative physiology.

[66]  M. Donowitz,et al.  Squalamine, a novel cationic steroid, specifically inhibits the brush-border Na+/H+exchanger isoform NHE3. , 1999, American journal of physiology. Cell physiology.